Leerink Partners Initiates Coverage on 10x Genomics (NASDAQ:TXG)

Leerink Partners assumed coverage on shares of 10x Genomics (NASDAQ:TXG – Free Report) in a research note released on Tuesday morning, Marketbeat Ratings reports. The brokerage issued an outperform rating and a $35.00 price objective on the stock. TXG has been the subject of several other research reports. Deutsche Bank Aktiengesellschaft cut 10x Genomics from […]